A guest post about the implications for the price of medications under the Pharmaceutical Benefits Scheme of current Free Trade Agreement negotiations – by Michael Whaites, an organiser with the NSWNMA.
A Free Trade Agreement (FTA) is currently being negotiated between Australia, USA and a number of Asia/Pacific countries (the Trans-Pacific Partnership Agreement – TPPA). The negotiations are being held in secret and the desired outcome is that corporations will have greater access to Australian markets. One of the problems with this is that our Pharmaceutical Benefits Scheme (PBS) is seen as a barrier to Free Trade.
Without the PBS, costs for medications in Australia would fall into line with costs in the US and that’s three to 10 times the price we currently pay. This would mean less people being able to afford their medications and more people filling our public hospitals.






